Replies to post #33685 on Plandai Biotechnology Inc (PLPL)

[Aquahoya]

Dude. The OTC was always high risk love affairs. What are you talking about. Almost like this is your first time.

[Kyle279]

PLPL has been groomed for an uplist to NASDAQ for the entire search for a merger. It’s why I’ve been actively accumulating. Any company coming in and investing over $3 million is not planning on sticking around in the OTC muck. It’s akin to IGPK in my view. Probably a RS to clean up the structure before uplisting. Likely a year or so down the road.

[zombywolf]

Explain "Garbage"? You dont appear to be very bright, but I cant wait to see your moronic response (I expect crickets) and definition here. I didnt see you listed in the fins just released, so you know nothing about what is going on. Please hurry and show all what an idiot response looks like when you know less than nothing.

[reena969]

I'd like to add a small correction to your comment. The challenge with the OTC arises when it becomes too organized and too many individuals begin profiting excessively. This is why the SEC implemented Rule 15c2-11. The OTC started becoming a lucrative opportunity for small investors. For instance, buying a million shares of PLPL at $0.0005 and selling them at $0.006 results in a 1100% increase. I started trading in the OTC, and as long as money was being lost in these high-risk stocks, the SEC didn't intervene. However, the issue arose when individuals started making millions in the OTC faster than in other exchanges.

In a new report from Wintermute, the market maker and liquidity provider, said that its over-the-counter (OTC) volume was up 400% throughout the year as volumes moved off-exchanges.

Essentially, the OTC drew the SEC's attention. It's akin to a casino: if a particular table sees too many winners, does the casino allow it to continue unchanged?